JDD Multimedia

Best Practices & Practical Pearls for Safely Reopening Derm Practices

The Journal of Drugs in Dermatology (JDD)  is proud to present an essential education program on the topic of guidelines for safely reopening dermatology practices during the COVID-19 pandemic, lead by Dr. Jeffrey S. Dover, Director of SkinCare Physicians in Chestnut Hill, Massachusetts and a panel of dermatology thought leaders.

This video series was produced by the Journal of Drugs in Dermatology and supported in part by Alastin Skincare, Endo Aesthetics. Ortho Dermatologics, and Sciton.

Supported in part by

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Jeffrey S. Dover

Discussion Topics

  • Medical Office Preparedness
  • Managing the Office Environment
  • General Guidance
  • Cleaning & Disinfecting Practices
  • Practices
  • PPE and Medical Supplies

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Kavita Mariwalla

Discussion Topics

  • Clinical and Non-Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Anesthesia and analgesia
  • Injectables

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Thomas E. Rohrer

Discussion Topics

  • Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Post-Surgery Follow Up

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Terrence Keaney

Discussion Topics

  • Non-invasive body contouring
  • Energy-based procedures of the face and neck
  • Skin treatment procedures

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Nazanin Saedi

Discussion Topics

  • Employee health and training
  • Recognition of symptoms
  • Symptomatic patients and employees
  • Office arrival, check-in and check-out
  • Pre-screening patients

You May Also Like

A Consensus on Staphylococcus aureus Exacerbated Atopic Dermatitis and the Need for a Novel Treatment

| Atopic Dermatitis, Featured Articles, Latest News | No Comments
From the Vault: Expert Recommendations on Microbiome Balance, Secondary Infections, and Therapeutic Gaps Managing atopic dermatitis (AD) involves navigating a complex interplay between skin barrier dysfunction and microbial dysbiosis. As…

Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial

| Featured Articles, Latest News, Rosacea | No Comments
Investigating Clascoterone Cream 1% for Papulopustular Rosacea: Key Takeaways  This is a must-read article from JDD for clinicians seeking fresh therapeutic avenues for chronic facial dermatoses. Managing papulopustular rosacea often…
Journal of Drugs in Dermatology JDD featuring Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus

Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus

| Dyspigmentation, Featured Articles, Latest News | No Comments
From the Vault: Managing Recurrent Hyperpigmentation Beyond Standard Hydroquinone Regimens Given its complex pathogenesis, chronicity, and high rates of recurrence, melasma remains one of the most challenging conditions in aesthetic…